Does a rhythm-control strategy improve survival compared to a rate-control strategy in high-risk patients with atrial fibrillation?
A rhythm-control strategy offers no survival advantage over a rate-control strategy in high-risk patients with atrial fibrillation, while rate control may have a lower risk of adverse drug effects.
Management of atrial fibrillation with the rhythm-control strategy offers no survival advantage over the rate-control strategy, and there are potential advantages, such as a lower risk of adverse drug effects, with the rate-control strategy. Anticoagulation should be continued in this group of high-risk patients.
Wyse et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: